VivoSeq
Other

Tenofovir

1

Pipeline Programs↗

3

Active Trials↗

6

Companies Involved↗

Tenofovir is an early-stage landscape with 1 program across 6 companies. The most active players are Gilead, Johnson & Johnson, GSK.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Gilead logo

Gilead

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalBristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalA

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

TFV Rectal Douche

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

95

clinical trials

Completed77 · 81%
Unknown status8 · 8%
Terminated5 · 5%
Withdrawn2 · 2%
Active, not recruiting2 · 2%
Recruiting1 · 1%

Clinical Trials

Trial Activity

95 trials

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
Recruiting·Gilead logoGilead·Phase 1·NCT07055451·16 enrolled
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
Active, not recruiting·Gilead logoGilead·Phase 3·NCT06630286·609 enrolled
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
Active, not recruiting·Gilead logoGilead·Phase 2/3·NCT02016924·133 enrolled
Switch to Unboosted Atazanavir With Tenofovir Study
Completed·UUniversity of British Columbia·Phase 4·NCT01351740·50 enrolled
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Completed·CCONRAD·Phase 1·NCT01989663·78 enrolled
Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse
Completed·JJohns Hopkins University·Phase 1·NCT04195776·6 enrolled
Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects
Completed·HHumanis Saglık Anonim Sirketi·Phase 1·NCT06592300·42 enrolled
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Completed·AAbbott·Phase 3·NCT00043966·200 enrolled
Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC
Completed·GGuangxi Medical University·Phase 3·NCT02650271·240 enrolled
A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participants
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT02578550·126 enrolled
Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir
Completed·LLaboratorio Elea Phoenix S.A.·Phase 4·NCT03309566·24 enrolled
A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
Completed·—·Phase 1·NCT01575405·13 enrolled
Tenofovir Abacavir Platelet Activation Study
Completed·—·Phase 4·NCT02093585·43 enrolled
Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression
Completed·UUniversity of Maryland, Baltimore·N/A·NCT00344981·9 enrolled
Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel
Completed·CCONRAD·Phase 1·NCT01687205·31 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)